Structure |
Chemical Name |
CAS |
MF |
 |
4-((5,6-dimethoxy-1H-inden-2-yl)methyl)piperidine |
1026443-48-0 |
C17H23NO2 |
 |
epipinoresinol-4'-O-β-D-glucoside |
24404-49-7 |
C26H32O11 |
 |
Celecoxib Impurity |
170570-09-9 |
C18H16F3N3O2S |
 |
Indacaterol Impurity 7 |
1403389-05-8 |
C24H30N2O3 |
![tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate](../cas/20180601/gif/1883672-48-7.gif) |
tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
1883672-48-7 |
C29H38ClN7O4 |
 |
1-cyclopropyl-7-fluoro-6,8-dimethoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
C15H14FNO5 |
 |
cis-cyclo(Pro-Pro) |
19943-27-2 |
C10H14N2O2 |
 |
Ropivacaine-cycle |
1945965-95-6 |
C17H24N2O |
 |
4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide |
181696-12-8 |
C16H14N2O3S |
 |
Bupivacaine Impurity |
2125995-27-7 |
C18H29ClN2O |
 |
Brexpiprazole Impurity |
2059954-32-2 |
C17H21Cl2NO2 |
 |
BDJS-SH 2 |
36585-31-6 |
C12H18N2O2 |
 |
Acyclovir Impurity Q |
|
|
 |
Ampicillin EP Impurity M |
114977-84-3 |
C48H57N9O12S3 |
 |
Aprepitant Impurity 12 |
172673-23-3 |
C23H21F7N4O4 |
 |
Aprepitant Impurity 18 |
|
|
 |
Blonanserin impurity D |
|
|
 |
Captopril impurity 3 |
|
|
 |
Empagliflozin Impurity 18 |
|
|
 |
Empagliflozin Impurity 24 |
|
|
 |
FeBuxostat impurity 31 |
|
|
 |
Formoterol Fumarate Dihydrate EP Impurity I |
532414-36-1 |
C19H24N2O4 |
 |
Fosaprepitant Impurity 3 |
|
|
 |
Fosfomycin Trometamol EP Impurity D |
1262243-12-8 |
C10H25NO11P2 |
 |
Isavuconazole Impurity 17 |
|
|
 |
Isavuconazole Impurity 5 |
|
|
 |
Moxifloxacin Impurity 21 |
|
|
 |
Mupirocin EP Impurity A |
|
C26H44O9 |
 |
Nifendipine Impurity G |
74378-10-2 |
C15H14N2O6 |
 |
Olaparib Impurity 5 |
|
|
 |
Plerixafor Impurity 5 |
|
|
 |
Posaconazole Impurity 30 |
|
|
 |
Posaconazole Impurity 35 |
1370190-85-4 |
C14H13F2N3O |
 |
Posaconazole Impurity 51 |
357189-94-7 |
C37H40F2N8O5 |
 |
Posaconazole Impurity 59 |
|
|
 |
Ramosetron Impurity 13 |
183613-77-6 |
C17H13N3O |
 |
Sitafloxacin Impurity 2 |
|
|
 |
Sitagliptin Impurity 10 |
1253056-01-7 |
C16H14F6N4O2 |
 |
SofosBuvir Impurity 18 |
|
|
 |
sofosBuvir Impurity 35 |
|
|
 |
SofosBuvir Impurity 51 |
|
|
 |
SofosBuvir Impurity 58 |
|
|
 |
Sulbactam EP Impurity G |
|
|
 |
Ticagrelor impurity 21 |
|
|
 |
Tirofiban Impurity 13 |
|
C27H45N3O3 |
 |
Tofacitinib impurity U |
|
|
 |
Vortioxetine impurity S |
1815608-51-5 |
C18H22N2S |
 |
Linagliptin N-Acetyl Impurity |
1803079-49-3 |
C27H30N8O3 |
![(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid](../cas/20180601/gif/474668-76-3.gif) |
(1R,3R)-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid |
474668-76-3 |
C19H16N2O4 |
 |
Lidocaine Impurity |
70336-49-1 |
C20H22N2O2 |
![(E)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide](../cas/20180601/gif/214782-56-6.gif) |
(E)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide |
214782-56-6 |
C12H9F3N2O2 |
 |
Amoxicillin Impurity O |
|
C16H19N3O5S |
 |
Ampicillin Impurity R |
|
|
 |
Spectinomycin Impurity C |
|
|
![(2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](../cas/20180703/gif/1012341-52-4.gif) |
(2S,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-52-4 |
C23H29NO4 |
![Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate](../cas/20180703/gif/1038924-97-8.gif) |
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate |
1038924-97-8 |
C24H27NO4 |
 |
DONEPEZIL IMP |
923571-16-8 |
C24H22ClNO4 |
 |
Parecoxib Impurity N |
|
|
![5-[bis-(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester](../cas/20180703/gif/87475-54-5.gif) |
5-[bis-(2-Chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester |
87475-54-5 |
C18H25Cl2N3O2 |
 |
6-Hydroxykaempferol 3-Rutinoside -6-glucoside |
145134-63-0 |
C33H40O21 |
 |
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline |
85-63-2 |
C21H27NO4 |
 |
Linagliptin Impurity P |
|
|
 |
Linagliptin Impurity U |
|
|
 |
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzoic acid |
1917324-15-2 |
C18H21FN4O4 |
 |
N1,N4-bis((R)-1-(3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)succinamide |
|
C40H42F2N10O6 |
![ethyl ((1R,3aR,4aR,6S,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate](../cas/20180703/gif/618385-10-7.gif) |
ethyl ((1R,3aR,4aR,6S,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate |
618385-10-7 |
C29H33FN2O4 |
 |
(2R)-2-deoxy-2-fluoro-2-methyl-α/β-D-erythro-pentofuranosyl chloride-3,5-dibenzoate |
1621160-31-3 |
C20H18ClFO5 |
 |
Apremilast Impurity F |
|
|
 |
Etoricoxib Impurity 17 |
|
|
 |
Ibrutinib Impurity 3 |
1226872-27-0 |
C25H26N6O4 |
 |
Imatinib Impurity 2 |
1384131-91-2 |
C7H11NO |
 |
Mirabegron M5 (YM-538852) |
1365244-63-8 |
C18H22N2O2 |
 |
Sofosbuvir Impurity 6 |
|
|
 |
Vonoprazan Impurity 2 |
881733-36-4 |
C17H16FN3O2S |
 |
Atomoxetine EP impurity A |
56161-70-7 |
C16H19NO |
 |
Cinacalcet Impurity 21 |
|
|
 |
Dasatinib Impurity D |
|
|
 |
Doxofylline Impurity 1 |
1429636-74-7 |
C10H16N4O3 |
 |
Propofol Impurity |
2095678-97-8 |
C16H24O3 |
 |
Sitagliptin EP Impurity B |
1345822-87-8 |
C16H19F5N5O5P |
 |
Amifostine Impurity 2 |
|
|
 |
Brexpiprazole Impurity |
2138169-93-2 |
C41H47N5O2S2 |
 |
Cefoxitin impurity EF |
|
|
 |
Tenofovir Impurity 38 |
161760-09-4 |
C8H11O6PS |
 |
N-(4-methyl-3-(3-(4-((4-methylpiperazin-1-yl)methyl)benzoyl)guanidino)phenyl)-4-(4-methylpiperazin-1-yl)benzamide |
|
C33H42N8O2 |
 |
Apremilast |
1384440-16-7 |
C19H20N2O6S |
 |
XMUJPIDSOJTMMS-VTBMCCKRSA-N |
212505-49-2 |
C21H30O3 |
 |
XLMHAABXFLIUNQ-UHFFFAOYSA-N |
368451-15-4 |
C24H26O3 |
 |
NMEICKDXQPVPKK-UHFFFAOYSA-N |
120244-82-8 |
C16H19ClN2O |
 |
4-Methylpiperazine-1-carbonyl chloride |
39539-66-7 |
C6H11ClN2O |
 |
Epoxy Exemestane (6-Beta Isomer) |
152764-31-3 |
C20H24O3 |
 |
AFTMPFJWAIDLME-QWHCGFSZSA-N |
1808087-53-7 |
C15H19N3O3S |
![6-Cyclopropyl-10-fluorobenzo[k]phenanthridine](../cas/20180601/gif/1187966-95-5.gif) |
6-Cyclopropyl-10-fluorobenzo[k]phenanthridine |
1187966-95-5 |
C20H14FN |
![4-[2-fluoro-4-[2-(methylcarbamoyl)pyridin-4-yl]oxyanilino]-N-methylpyridine-2-carboxamide](../cas/20180601/gif/1855006-12-0.gif) |
4-[2-fluoro-4-[2-(methylcarbamoyl)pyridin-4-yl]oxyanilino]-N-methylpyridine-2-carboxamide |
1855006-12-0 |
C20H18FN5O3 |
![2,2'-((piperazine-1,4-disulfonyl)bis(2-ethoxy-5,1-phenylene))bis(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one)](../cas/20200611/gif/1255919-03-9.gif) |
2,2'-((piperazine-1,4-disulfonyl)bis(2-ethoxy-5,1-phenylene))bis(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one) |
1255919-03-9 |
C38H46N10O8S2 |
 |
Bortezomib Impurity P |
|
|
 |
Esmolol impurity A |
|
|
 |
(5-(4-fluorophenyl)thiophen-2-yl)(5-iodo-2-methylphenyl)methanol |
1818268-45-9 |
C18H14FIOS |
 |
2-propyl-1H-indene-1,3(2H)-dione |
14570-43-5 |
C12H12O2 |
 |
GLORIOSINE |
7411-12-3 |
C21H23NO6 |